{"id":"NCT05875701","sponsor":"Novavax","briefTitle":"Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines","officialTitle":"A Phase 3 Study to Evaluate the Immunogenicity and Safety of Novavax COVID-19 Vaccine(s) as Second or Subsequent Booster After mRNA Vaccines in Individuals 18 to 49 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-03-28","primaryCompletion":"2023-11-11","completion":"2023-11-11","firstPosted":"2023-05-25","resultsPosted":"2025-06-26","lastUpdate":"2025-06-26"},"enrollment":147,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["COVID-19"],"interventions":[{"type":"BIOLOGICAL","name":"NVX-CoV2373","otherNames":["SARS-CoV-2 rS/Matrix-M Adjuvant"]},{"type":"BIOLOGICAL","name":"SARS-CoV-2 rS antigen/Matrix-M Adjuvant","otherNames":["Updated Novavax COVID-19 vaccine"]}],"arms":[{"label":"NVX CoV2373 (Ancestral strain)","type":"EXPERIMENTAL"},{"label":"Updated COVID-19 Vaccine","type":"EXPERIMENTAL"}],"summary":"This is an open-label Phase 3 study evaluating the immunogenicity and safety of Novavax vaccine(s) with Matrix-Mâ„¢ adjuvant (ancestral strain NVX-CoV2373 and an alternative strain and/or multivalent Novavax vaccine) as booster doses following a series of primary and booster doses of authorized/approved mRNA vaccines followed by a single booster dose of NVX-CoV2373 in the Novavax 2019nCoV-307 study (NCT05463068).","primaryOutcome":{"measure":"Neutralizing Antibody (Nab) for SARS-CoV-2 Wildtype Virus (Wuhan) Responses Expressed as Geometric Mean Titers (GMT)","timeFrame":"Day 28","effectByArm":[{"arm":"NVX CoV2373 (Ancestral Strain)","deltaMin":173.2,"sd":null},{"arm":"NVX-CoV2540(Updated COVID-19 Vaccine)","deltaMin":159.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":104},"commonTop":["COVID-19","Lymphadenopathy"]}}